American Medical Systems Holdings, Inc. Under Investor Investigation

If you purchased American Medical Systems Holdings, Inc. (NASDAQ: AMMD) and currently continue to hold those NASDAQ:AMMD shares, and/or if you have any information relating the investigation, you have certain options and you should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this investigation, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
American Medical Systems Holdings
Affected Securities: 
NASDAQ: AMMD

Following the announcement that American Medical Systems Holdings will be acquired by Endo Pharmaceuticals an investigation on behalf of investors of American Medical Systems Holdings, Inc. (NASDAQ:AMMD) over possible breaches of fiduciary duty was announced.

The investigations by law firms concern whether certain directors and officers at American Medical Systems Holdings, Inc. or others breached their fiduciary duties in connection the proposed takeover.

On Monday, April 11, 2011 American Medical Systems (AMS) (Nasdaq: AMMD) and Endo Pharmaceuticals (Nasdaq: ENDP) announced that they have entered into an agreement under which Endo Pharmaceuticals will acquire American Medical Systems for $30 per share, or $2.9 billion in cash, which includes the assumption and repayment of $312 million of AMS debt.

In response to the takeover news shares of American Medical Systems Holdings, Inc. (Public, NASDAQ:AMMD jumped from $22.39 during Friday to $29.51 per share.

However, American Medical Systems has performed well for its investors in the past. American Medical Systems Holdings’ 52week Total Revenue increased from $463.93million eported on Dec 29, 2007 to $542.32million reported on January 1 2011. Its Net Income rose over the same time frame from $4.05million to $87.01million.

Therefore the investigation concerns whether the American Medical Systems Holdings Board of Directors undertook an adequate and fair sales process to obtain fair consideration for all shareholders of American Medical Systems Holdings, Inc. (NASDAQ:AMMD) and breached their fiduciary duties to American Medical Systems (AMMD) shareholder by failing to adequately shop the Company before entering into any transaction.

The investigation also concerns whether Endo Pharmaceuticals would underpay for NASDAQ:AMMD shares, thus unlawfully harming AMMD stockholders. A potential class action lawsuit would seek to maximize the amount of money and information American Medical Systems Holdings (NASDAQ:AMMD) shareholders would receive in a buyout, so the law firm.